The incidence of tumor formation in our model was considerably lower than in other hGFAP-Cre driven transgenic models, in which penetrance was 100% (hGFAP-Cre x LSL-SmoM2; Schüller et al., Cancer Cell 2008). This evidence concerns the gene HGFAC and cancer.